Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2017 | Challenges with comorbidities and dementia

Dorota Religa • 24 Jun 2017
EAN 2017
Dementia

Dorota Religa, MD, PhD from the Karolinska Institute, Solna, Sweden discusses comorbidities and dementia at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands. Dr Religa explains that comorbidities such as hypertension and heart failure are common but there are no clear guidelines on how to treat them.

More from Dorota Religa

Anti-amyloid therapy for Alzheimer's disease: beyond the 18-month mark
2:33
Anti-amyloid therapy for Alzheimer's disease: beyond the 18-month mark
Dorota Religa • 22 Mar 2024
Will long-term anti-amyloid treatment show greater clinical benefit?
0:50
Will long-term anti-amyloid treatment show greater clinical benefit?
Dorota Religa • 22 Mar 2024
Digital frailty screening in dementia
1:24
Digital frailty screening in dementia
Dorota Religa • 22 Mar 2024
Most patients excluded from using current anti-amyloid therapies in Alzheimer’s disease
4:28
Most patients excluded from using current anti-amyloid therapies in Alzheimer’s disease
Dorota Religa • 22 Mar 2024

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals